Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Residual”

1,535 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,535 results

Very early researchStudy completedNCT04130152
What this trial is testing

Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 22
Not applicableLooking for participantsNCT06899048
What this trial is testing

The Association Between Residual Neuromuscular Block Risk Prediction Score and the Train-of-Four Ratio

Who this might be right for
Muscle Relaxants
Assiut University 91
Large-scale testing (Phase 3)UnknownNCT01088737
What this trial is testing

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

Who this might be right for
Lentigo Maligna
Medical University of Graz 60
Not applicableStudy completedNCT02910934
What this trial is testing

Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique

Who this might be right for
Malaria
PATH 3,915
Post-approval studies (Phase 4)UnknownNCT06025071
What this trial is testing

Residual Inflammatory Risk-Guided colcHicine in Elderly Trial

Who this might be right for
Percutaneous Coronary InterventionMultivessel Coronary Artery DiseaseElderly Patients+1 more
Chinese Academy of Medical Sciences, Fuwai Hospital 800
Not applicableStudy completedNCT03915847
What this trial is testing

Evaluation of Cesarean Scar After Three Different Uterine Closure Technis

Who this might be right for
Cesarean Section, RepeatedCesarean, Uterine Scar ThicknessCesarean, Residual Myometrial Thickness
Ataturk University 90
Not applicableUnknownNCT02755363
What this trial is testing

Effects of Osteopathic Techniques on Residual Volume in Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
COPD
Medical University of Warsaw 20
Testing effectiveness (Phase 2)Looking for participantsNCT07067268
What this trial is testing

Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Fudan University 76
Testing effectiveness (Phase 2)Ended earlyNCT01088035
What this trial is testing

Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma

Who this might be right for
Ependymoma
Ann & Robert H Lurie Children's Hospital of Chicago 75
Early research (Phase 1)Ended earlyNCT00041691
What this trial is testing

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery

Who this might be right for
Colorectal Neoplasms
Gilead Sciences 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT07100691
What this trial is testing

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

Who this might be right for
Pulmonary Aspiration During Anaesthetic InductionGastric Emptying TimePreoperative Risk Assessment+1 more
Mater Misericordiae University Hospital 80
Not applicableStudy completedNCT06371378
What this trial is testing

Effect of Different Peep Values on Gastric Residual Volume

Who this might be right for
Respiratory Aspiration of Gastric Content
Ankara City Hospital Bilkent 111
Not applicableUnknownNCT05323162
What this trial is testing

Encapsulated Faecal Microbiota Transplantation to Preserve Residual Beta Cell Function in Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes
Nordin Hanssen 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06570915
What this trial is testing

Daratumumab for T Cell ALL With MRD-positive After Standard Chemotherapy

Who this might be right for
ALL, Adult
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableLooking for participantsNCT06991868
What this trial is testing

Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)

Who this might be right for
NMIBCMIBCUTUC
Peking University First Hospital 300
Not applicableStudy completedNCT02890225
What this trial is testing

Comparison Of External Physical Vibration Lithecbole(EPVL) In Different Time After Retrograde Intrarenal Surgery(RIRS)

Who this might be right for
Calculi
Second Affiliated Hospital of Zhengzhou University 1
Testing effectiveness (Phase 2)Looking for participantsNCT05343013
What this trial is testing

TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 25
Not applicableLooking for participantsNCT06744296
What this trial is testing

Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Massachusetts Eye and Ear Infirmary 75
Not applicableUnknownNCT02872662
What this trial is testing

Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT

Who this might be right for
MDSSCTMRD
Nordic MDS Group 200
Not applicableStudy completedNCT02716103
What this trial is testing

Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 45
Load More Results